Explaining racial differences in prostate cancer mortality. - Wikidata - awgldk - TriplyDB

Explaining racial differences in prostate cancer mortality.

Explaining racial differences in prostate cancer mortality.

http://www.wikidata.org/entity/Q46526838

about

'Race' and prostate cancer mortality in equal-access healthcare systems Multilevel Factors Associated With Overall Mortality for Men Diagnosed With Prostate Cancer in Florida.Proteomic characterization of paired non-malignant and malignant African-American prostate epithelial cell lines distinguishes them by structural proteins.Feasibility Study of Engaging Barbershops for Prostate Cancer Education in Rural African-American Communities.Health disparities and cancer: racial disparities in cancer mortality in the United States, 2000-2010.Rural-urban differences in the clinico-pathologic profiles of Jamaican men with prostate cancer Associations of prostate cancer risk variants with disease aggressiveness: results of the NCI-SPORE Genetics Working Group analysis of 18,343 cases.Racial disparities in gastrointestinal cancers-related mortality in the U.S. population.Prostate-specific antigen testing in inner London general practices: are those at higher risk most likely to get tested?Racial Differences in the Surgical Care of Medicare Beneficiaries With Localized Prostate Cancer.Beyond the black box: a systematic review of breast, prostate, colorectal, and cervical screening among native and immigrant African-descent Caribbean populations.Immunoseroproteomic Profiling in African American Men with Prostate Cancer: Evidence for an Autoantibody Response to Glycolysis and Plasminogen-Associated Proteins.Under-representation of racial minorities in prostate cancer studies submitted to the US Food and Drug Administration to support potential marketing approval, 1993-2013.Prostate cancer in men of African origin.Is prostate cancer different in black men? Answers from 3 natural history models.Beliefs Regarding Prostate Cancer Screening Among Black Males Aged 18 to 40 Years.Age-related racial disparities in prostate cancer patients: A systematic review.Impact of ethnicity on the outcome of men with metastatic, hormone-sensitive prostate cancer.Development, validation and comparison of two nomograms predicting prostate cancer at initial 12-core biopsy.Minimally invasive prostate cancer detection test using FISH probes.Detection of High Grade Prostate Cancer among PLCO Participants Using a Prespecified 4-Kallikrein Marker Panel.Number of Unfavorable Intermediate-Risk Factors Predicts Pathologic Upstaging and Prostate Cancer-Specific Mortality Following Radical Prostatectomy: Results From the SEARCH Database.Population-Based External Validation of the Updated 2012 Partin Tables in Contemporary North American Prostate Cancer Patients.Racial/ethnic differences in the relative risk of receipt of specific treatment among men with prostate cancer DNA methylation profiles in African American prostate cancer patients in relation to disease progression.Association between very small tumour size and increased cancer-specific mortality after radical prostatectomy in lymph node-positive prostate cancer.Interracial differences in prostate cancer progression among patients from the United States, China and Japan Predictors of positive surgical margins and their location in Korean men undergoing radical prostatectomy.Racial disparities in survival after diagnosis of prostate cancer in Kentucky, 2001-2010.Exome Sequencing of African-American Prostate Cancer Reveals Loss-of-Function ERF Mutations.Prostate cancer survival in the United States by race and stage (2001-2009): Findings from the CONCORD-2 study.Genetic hitchhiking and population bottlenecks contribute to prostate cancer disparities in men of African descent.Yonsei nomogram to predict lymph node invasion in Asian men with prostate cancer during robotic era.African-American Prostate Cancer Disparities.African-American men and prostate cancer-specific mortality: a competing risk analysis of a large institutional cohort, 1989-2015.Technical Feasibility of Tissue Microarray (TMA) Analysis of Tumor-Associated Immune Response in Prostate Cancer.

P2860

Q27008227-5D5B504B-3A1A-4D29-A538-8B75EB000B28 Q33693397-7DA124AB-2EA2-4868-98BA-50CB73C74298 Q33892680-B5F03AD0-9A7F-4855-9369-36DBEA4541B0 Q35327666-E8576D76-53C8-475E-87D9-BBA2641780B0 Q35437586-DD4523EB-F2C9-470C-97D2-E94A8FF7971D Q36096858-CB5E4630-9B9C-4CD6-87A2-DDB371AFC5BA Q36100579-90C002B6-B3E2-465F-A482-D399BFD474F4 Q36784183-C82CBC48-5CDF-4E30-A0C9-18E054606029 Q37100980-C7A4E06B-21EB-49F2-A761-6A8F2B1E0A1A Q37246641-07734A35-A437-49F4-88E2-BF284B3BD91C Q38187561-6FC0527B-CA0A-4697-93D0-7E5088FC9696 Q38386585-F3E10B89-920E-40DC-9BBC-F56D6A115B7A Q38391188-595A9C1C-D7E2-4D1E-8361-9EEB50573C0A Q38683379-A6B854C3-2FB2-4253-9ED8-FB3A5D890F07 Q38823794-C67F3E24-FDBD-4614-8B90-02B03DB27662 Q38892954-D8D2179C-A9BA-4C2F-A78D-465A1F7DC647 Q38972905-9BC1BEEC-27E1-405F-83B6-30849D271EE5 Q39038671-CCAC8FFF-9405-40BB-B2DF-BAB5B8DA277A Q40181136-348F07A7-1022-4C64-BA7D-0EB8D5D122BE Q40399854-E4D7504C-CC0C-4BF3-BF83-A63D9BD56B69 Q40417671-2C7A0A38-D17C-4BFF-8CE4-BDEA720EAD51 Q40561460-2FCB90EF-36AB-4F9D-81F9-67B8896D2264 Q40561515-99F1516F-7F61-4726-A3C1-E57599AA0A5E Q40762402-A7E747B4-34E0-4FD1-960B-2F17651933ED Q40894878-1EE3C270-E323-4570-9C77-84EAFE5BEC6E Q41520637-CA127B6A-F2F4-4AC6-8986-2DCFEF28F92F Q41842248-6185294F-300E-4583-B746-9D40AEDCDD3C Q42458558-9332FC3C-B3F8-4AE9-8EAA-BBA4650D608A Q44740342-6260DD51-6F57-44F4-864E-2836EEC598F9 Q46885929-8AEDAFAE-9910-47B9-907F-EDE8CFD7A4C8 Q47368351-EA4AAA1C-835E-46AC-B903-A31B5770DD68 Q50036859-9721AB9B-C4E5-48C9-9548-ACE4EDA488B2 Q51167329-20D92B59-F31F-40FF-B2F5-9EAEB7323879 Q51807661-A5B9F010-EEE4-4ED4-A6D0-7FF581F581F4 Q53076421-550EC416-4750-4FC7-B889-10EC29E9EC4A Q55279811-0204E325-07E7-4714-94EB-A0FFBBB65DC4

P2860

Explaining racial differences in prostate cancer mortality.

http://www.wikidata.org/entity/Q46526838

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh-hant

name

Explaining racial differences in prostate cancer mortality.

@en

Explaining racial differences in prostate cancer mortality.

@nl

type

label

Explaining racial differences in prostate cancer mortality.

@en

Explaining racial differences in prostate cancer mortality.

@nl

prefLabel

Explaining racial differences in prostate cancer mortality.

@en

Explaining racial differences in prostate cancer mortality.

@nl

P1433

Q46526838-A207D896-52A9-4A8C-B953-7880284B1A5A

P1476

Q46526838-1A9B34F1-8B7E-4201-918F-330C7B8BE947

P2093

Q46526838-4EAABC56-A19A-4FC7-97FF-15E1AF6802A2

Q46526838-D12A942E-28D8-40C0-871C-C618DC2A0E1E

P2860

Q46526838-0B270F41-FD5D-4151-933F-60CC5F6F4671

Q46526838-0D7BA761-5AEC-4908-ABB4-855C7A168830

Q46526838-22C22B68-4E88-4E03-B342-BDEADBA59069

Q46526838-22F71EC7-96FC-4E33-92DE-7ECCE4BFF767

Q46526838-281F345B-BE3D-4660-9F1E-5F5E64FEC030

Q46526838-3D60FAFA-CEC8-4383-805B-10B19B4671EA

Q46526838-3F1B84FB-F67D-4752-BBF9-2F9360C715A4

Q46526838-460FDCF3-7847-4A1C-8C57-1875493C0395

Q46526838-4CADD276-21D4-4CB6-8C4C-751011A0CADE

Q46526838-5D3548F5-579F-4C43-BED4-3B39264D02A1

P304

Q46526838-BD7B7BAD-18A6-44D9-9F69-247971B06644

P31

Q46526838-7AE82166-B90D-439B-BA04-6C674A6EFAC9

P356

Q46526838-D92A67A5-8CA3-43A5-B694-5ACEEE5FA7B3

P407

Q46526838-1FC97C65-0D08-4182-9894-546EC9A46CC6

P433

Q46526838-46D868DC-9599-4B28-8FD7-2ECDEFAFD4B2

P478

Q46526838-5D99ED5B-636F-456F-9786-BA37DDC69205

P50

Q46526838-59AF7272-5711-4D17-A010-A6E051B18CA0

P577

Q46526838-DEF779A8-236D-40DB-9D1A-0475F604521E

P5875

Q46526838-AA1F49A2-5F36-4093-9239-5163912BB3D8

P698

Q46526838-7C9765F7-0A10-415B-A2D7-362D14D8E4EE

P356

P1433

P1476

Explaining racial differences in prostate cancer mortality.

@en

P2093

David M Cutler

http://www.w3.org/2001/XMLSchema#string

Nancy L Keating

http://www.w3.org/2001/XMLSchema#string

P2860

Mortality results from a randomized prostate-cancer screening trial

Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults

Secular trends in mortality from common cancers in the United States by educational attainment, 1993-2001

Screening and prostate-cancer mortality in a randomized European study

Development of a comorbidity index using physician claims data.

Limits of observational data in determining outcomes from cancer therapy.

Systematic review: comparative effectiveness and harms of treatments for clinically localized prostate cancer.

Impact of ethnicity on primary treatment choice and mortality in men with prostate cancer: data from CaPSURE.

Data and trends in cancer screening in the United States: results from the 2005 National Health Interview Survey.

Racial differences in PSA screening interval and stage at diagnosis.

P304

4280-4289

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CNCR.27379

http://www.w3.org/2001/XMLSchema#string

P407

P433

17

http://www.w3.org/2001/XMLSchema#string

P478

118

http://www.w3.org/2001/XMLSchema#string

P50

Glen B. Taksler

P577

2012-01-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221749225

http://www.w3.org/2001/XMLSchema#string

P698

22246942

http://www.w3.org/2001/XMLSchema#string